HCA 255 The advances made in health care have been exponentially increasing over the past hundred years

HCA 255 Topic 7 DQ 1

The advances made in health care have been exponentially increasing over the past hundred years; however the availability of some of these advances has been blunted by lengthy approval processes, excessive costs, limited access, or regulatory requirements.  Should these factors be modified. If so, how?

Answer:

The advances made in health care have been exponentially increasing over the past hundred years. In the present day, however, many advances are being thwarted by either extensive approval procedures or excessive costs when we should be concerned about this issue. The bigger question is should we change these factors, if so how?

Drugs and medical devices are the greatest advances over the past century. Examples such as heart valves, artificial limbs, pacemakers, and cancer drugs would not have been possible without the technology that made them core components of today’s science.   However, many advances could experience a decrease in availability to the public if changes to government approval processes, excessive costs, limited access and regulatory requirements are not modified.

Should these factors be modified. If so, how?

What are the benefits of newer drugs and technologies in healthcare, such as new molecular entities (NMEs) and other biologics, biosimilars, important advances in genetic tests, and advanced imaging approaches?

In its February 2017 issue, the Journal of the American Medical Association looked at Medicare data from 2004-2012 and showed that “the cost of approved drugs more than doubled” during that time (). This trend is disturbing because many newly approved drugs do not offer enough benefit over existing medications to justify their cost.  The major problems in the pharmaceutical industry are twofold: excessive regulation and limited access to new medications.  As this paper will show, both of these issues limit competition, which results in higher prices.

If a new drug that could significantly improve the health of people with a serious or life-threatening condition was held up in regulatory review, or had to be given limited availability because of costs, first do no harm should apply to this situation. If a drug were being overused by certain patient populations and causing unnecessary adverse effects, it should be managed by use of guidelines, reimbursement policy and access. And if new diagnostic tests like pharmacogenomic tests were available but not reimbursed due to the cost per test, there should be policies in place to cover those costs so patients can be properly treated and managed.

It is incredibly important that the factors that hold back advances in medical care be resolved. With the assistance of technology, healthcare costs are on the rise. Allowing for increased technological advances in medicine will alleviate some of these costs, which will lead to increased access to medical care to all patients.

Reaching the way that it is today; health care is an experience that goes beyond mere medical profession. It encompasses all aspects of individuals’ lives and thus, therapeutic decisions should be made by the individual in consultation with their loved ones and health care team.

Should government implement a comprehensive reform package that forces health care providers in the United States to comply with established laws and ensures all Americans are afforded accessible, affordable health care? Health reform is considered the most controversial issue President Barack Obama has faced since he assumed the office of presidency.

Question:

HCA 255 Topic 7 DQ 1

The advances made in health care have been exponentially increasing over the past hundred years; however the availability of some of these advances has been blunted by lengthy approval processes, excessive costs, limited access, or regulatory requirements.  Should these factors be modified. If so, how?

Scroll to Top